Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.43 |
| ▸ | DRD2 | P14416 | 3/20 | 0.43 |
| ▸ | DRD4 | P21917 | 3/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2994658 | 1.00 | MTNR1A (0.43) | MTNR1AMTNR1BDRD2DRD4SLC6A2 | |
| SCHEMBL430079 | 0.88 | MTNR1A (0.53) | MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31043514 | 0.88 | MTNR1A (0.53) | MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL649686 | 0.82 | BRD4 (0.42) | MTNR1AMTNR1BDRD2DRD4KMT2A | |
| SCHEMBL2510545 | 0.81 | KDM4E (0.40) | DRD2SLC6A2SLC6A4SLC6A3KDM4E | |
| SCHEMBL29505018 | 0.77 | TEAD1 (0.60) | DRD2KMT2AMEN1KDM4EGAA | |
| SCHEMBL22719616 | 0.77 | TEAD1 (0.60) | DRD2KMT2AMEN1KDM4EGAA | |
| SCHEMBL9621553 | 0.76 | HTT (0.62) | KMT2AHTTPOLBSMN1; SMN2ALDH1A1 | |
| SCHEMBL26620598 | 0.75 | MTNR1A (0.52) | MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL648876 | 0.73 | DPP4 (0.43) | MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273754-B2 | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds | ARQULE, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-8273754-B2 | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds | ARQULE, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-8273754-B2 | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds | ARQULE, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| WO-2010078430-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | US | disclosed |
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | US | disclosed |
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | DPYD, MKI67, TYMP | MTNR1A 1366/4885MTNR1B 921/4885DRD2 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.